{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-008016","form_type":"8-K","ticker":"ADTX","cik":"0001726711","company_name":"Aditxt, Inc.","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.275685+00:00","generated_at":"2026-06-06T15:06:05.091591+00:00","sec_items":["1.01","5.03","3.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aditxt acquires Brain Scientific EEG assets; issues $6M Series B-1 preferred","bullets":["Acquisition includes 16 patents and flagship NeuroCap™ and NeuroEEG™ products for neurology.","Aditxt issued 6,000 shares of Series B-1 Convertible Preferred Stock (stated value $6M) to Brain Scientific creditors.","Aditxt exchanged a $2.625M secured promissory note for 2,625 shares of Series B-2 Convertible Preferred Stock.","Global EEG devices market valued at $1.06B in 2022, expected to grow at 10.2% CAGR through 2030.","Acquired assets assigned to Pearsanta, Aditxt's majority-owned subsidiary, entering neurological diagnostics market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-008016","json":"https://secwatch.observer/filing/0001213900-24-008016.json","markdown":"https://secwatch.observer/filing/0001213900-24-008016.md","text":"https://secwatch.observer/filing/0001213900-24-008016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024008016/0001213900-24-008016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024008016/ea192454-8k_aditxtinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:06:05.091591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aecc5076fe1dd1b2b6a44d1092bb88331b5f1243","claim":"Aditxt, Inc. entered into Assignment and Assumption Agreement with Agent of certain secured creditors of Brain Scientific, Inc. and Philip J. von Kahle (effective 2024-01-24).","evidence_excerpt":"On January 24, 2024, Aditxt, Inc., a Delaware corporation (the “ Company ”) entered into an Assignment and Assumption Agreement (the “ Assignment Agreement ”) with the agent (the “ Agent ”) of certain secured creditors (the “ Brain Creditors ”) of Brain Scientific, Inc., a Nevada corporation (“ Brain Scientific ”) and Philip J. von Kahle (the “ Seller ”), as assignee of Brain Scientific and certain affiliated entities (collectively, the “ Brain Companies ”) under an assignment for the benefit of creditors pursuant to Chapter 727 of the Florida Statutes.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024008016/0001213900-24-008016-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Agent of certain secured creditors of Brain Scientific, Inc. and Philip J. von Kahle"},{"label":"Effective","value":"2024-01-24"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}